Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRA16 in Enteric Hyperoxaluria
NCT07871669Phase 2Not yet recruiting
- Sponsor
- Wuhan Kangfude Urolithiasis Institute
- Start
- Mar 2027
- Primary completion
- Mar 2028
01
Overview
A Phase 2 trial of TRA16 in enteric hyperoxaluria (EH), sponsored by Wuhan Kangfude Urolithiasis Institute. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
TRA16
03
Conditions
enteric hyperoxaluria (EH)
Beyond the preview
Go deeper on NCT07871669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07871669.